跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Retagliptin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Retagliptin
Approved
STANDARD
Retagliptin
Lee Pharma Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
0d5bd0c478ff651b
Company
Lee Pharma Limited
Type
Standard
Approval Details
Approval Id
0d5bd0c478ff651b
Drug Approval Philippines Name
Retagliptin
Product Name
Retagliptin
Registration Number
DRP-12576-1
Brand Name
Retagliptin
Generic Name
Vildagliptin
Dosage Form
Tablet
Dosage Strength
50 mg
Manufacturer
Lee Pharma Limited
Importer
Aglobal Care, Inc
Distributor
Reta Drug
Issuance Date
25 May 2023
Expiry Date
06 September 2027
Pharmacologic Category
Hypoglycemic Agent [Dipeptidyl Peptidase 4 (DPP-4) Inhibitor]
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
0d5bd0c478ff651b
Type
Standard
Back to Philippines FDA Approvals